Replies to post #245777 on NorthWest Biotherapeutics Inc (NWBO)

[jondoeuk]

They are https://www.fiercebiotech.com/biotech/genentech-lays-310-million-wager-biontech-s-mrna-cancer-vaccine-platform https://www.businesswire.com/news/home/20190104005112/en/Adaptive-Biotechnologies-Enter-Worldwide-Collaboration-License-Agreement

[Hansm7777]

Exactly, but what I'm seeing is a possible merging of capital $$$ for NWBO by Merck & Roche for securing the complete acquisition of NWBO. Merck and Roche merge and streamline synergies for massive savings. Hence, the outlay of $50+ Billion for all of NWBO will be made back within three years. Their combined equities will surge them past JnJ and probably within three years of commercializing the DCVax platform would put them beyond $500+ Billion in market cap. Think about it. It's a win all around except for the remaining BP competitors.
Hans